Finance

Lists
CMXHF:OTCMKTS
CSL Ltd
$ 121.10
0.00%
(0.00) 1D
10-р сарын 9, 12:22:41 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CMXHF...
Mkt. cap
89.69 тэрбум
Avg. vol.
167.00
Volume
0.00
52-wk high
$ 148.36
52-wk low
$ 63.84
Beta
0.56
Shares outstanding
479.88 сая
No. of employees
29 мян
Mkt. cap
89.69 тэрбум
Avg. vol.
167.00
Volume
0.00
52-wk high
$ 148.36
52-wk low
$ 63.84
Beta
0.56
Shares outstanding
479.88 сая
No. of employees
29 мян
News stories
From web sources and news partners
Profile
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
About CSL Ltd
CEOPaul McKenzie
Employees29 мян
Founded1916
HeadquartersМельбурн, Викториа, Австрали
Sector-
Websitecsl.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
4.17 тэрбум
4.17 тэрбум
3.73 тэрбум
3.73 тэрбум
Cost of goods sold
1.94 тэрбум
1.94 тэрбум
1.93 тэрбум
1.93 тэрбум
Cost of revenue
1.94 тэрбум
1.94 тэрбум
1.93 тэрбум
1.93 тэрбум
Research and development expenses
300.00 сая
300.00 сая
311.50 сая
311.50 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
612.50 сая
612.50 сая
693.00 сая
693.00 сая
Operating expense
912.50 сая
912.50 сая
1.00 тэрбум
1.00 тэрбум
Total operating expenses
2.85 тэрбум
2.85 тэрбум
2.93 тэрбум
2.93 тэрбум
Operating income
1.32 тэрбум
1.32 тэрбум
802.00 сая
802.00 сая
Other non operating income
-
-
-
-
EBT including unusual items
190.00 сая
190.00 сая
-2.23 тэрбум
-2.23 тэрбум
EBT excluding unusual items
1.22 тэрбум
1.22 тэрбум
699.50 сая
699.50 сая
Income tax expense
47.00 сая
47.00 сая
-597.50 сая
-597.50 сая
Effective tax rate
24.74%
24.74%
26.75%
26.75%
Other operating expenses
-
-
-
-
Net income
200.50 сая
200.50 сая
-1.49 тэрбум
-1.49 тэрбум
Net profit margin
4.81%
4.81%
-39.92%
-39.92%
Earnings per share
-
-
-
-
Interest and investment income
9.00 сая
9.00 сая
6.00 сая
6.00 сая
Interest expense
-106.50 сая
-106.50 сая
-108.50 сая
-108.50 сая
Net interest expenses
-97.50 сая
-97.50 сая
-102.50 сая
-102.50 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
1.56 тэрбум
1.56 тэрбум
974.00 сая
974.00 сая
Gain or loss from assets sale
22.50 сая
22.50 сая
500.00 мян
500.00 мян
AI content may include mistakes. Learn more
Google аппс